Repligen | RGEN - أصول متداولة





أصول متداولة تغيير تاريخ
Agilent USD 4.69B 70M 2026-06
Align Technology USD 2.73B 63.03M 2026-09
Bio Techne USD 744.4M 56.35M 2026-06
BioMarin Pharmaceutical USD 3.97B 633.45M 2026-06
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Bruker USD 2.22B 121.4M 2026-06
Charles River Laboratories USD 1.53B 40.3M 2026-06
Danaher USD 14.79B 1.41B 2026-09
Dentsply International USD 1.93B 83M 2026-06
General Electric Aerospace USD 41.53B 1.83B 2026-09
Henry Schein USD 4.6B 104M 2026-06
Illumina USD 3.04B 201M 2026-09
IQVIA Holdings USD 6.45B 225M 2026-09
Mettler Toledo International USD 1.35B 15.48M 2026-06
Myriad Genetics USD 289M 23.8M 2026-06
OraSure Technologies USD 222.94M 17.84M 2026-06
Pacific Biosciences Of California USD 338.64M 30.88M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Repligen USD 1.24B 41.43M 2026-09
Revvity USD 2.3B 169.4M 2026-06
Standard Biotools USD 516.87M 4.59M 2026-06
Thermo Fisher Scientific USD 25.62B 2.25B 2026-09
Waters USD 3.9B 186M 2026-06
West Pharmaceutical Services USD 1.82B 9M 2026-09